Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi
- PMID: 9529074
- PMCID: PMC108081
- DOI: 10.1128/IAI.66.4.1507-1512.1998
Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi
Abstract
The serious morbidity associated with Lyme borreliosis has focused considerable effort on the development of a comprehensive vaccine for protection against infection with Borrelia burgdorferi. Induction of borreliacidal antibody by vaccination or infection has been shown to correlate with protection of humans and animals against infection with the Lyme spirochete. In this report, we showed that high levels of borreliacidal antibody (titer of 1,280) were produced in vitro when T and B cells from hamsters 14 days after vaccination were incubated with macrophages and B. burgdorferi. By contrast, T and B cells from hamsters 7 or 21 days after vaccination failed to initiate production of borreliacidal activity. Furthermore, the T cells from hamsters 7 or 21 days after vaccination inhibited the in vitro production of borreliacidal antibody when cocultured with T and B cells obtained from hamsters 14 days after vaccination. When cell-free supernatants from the suspensions of T and B cells from hamsters 14 days after vaccination were absorbed with recombinant OspA, they lost nearly all borreliacidal activity. The removal of anti-OspA antibody resulted in a decrease in borreliacidal titer from 1,280 to less than 4. These results demonstrate that T cells from vaccinated animals can prevent a sustained production of protective borreliacidal antibody.
Figures
), 14
(░⃞), or 21
(▩) days after
vaccination. The titers of borreliacidal antibody were determined by
inoculating dilutions of the cell-free suspensions with B.
burgdorferi and complement, incubating for 20 h at 32°C,
adding acridine orange, and determining the number of
fluorescence-stained B. burgdorferi by flow cytometric
analysis. Controls included suspensions containing macrophages and
B. burgdorferi, macrophages, B. burgdorferi, and
immune cells. When the borreliacidal assays were repeated, results were
identical or varied by only a dilution.References
-
- Aberer E, Brunner C, Suchanek G, Klade H, Barbour A, Stanek G, Lassmann H. Molecular mimicry and Lyme borreliosis: shared antigenic determinant between Borrelia burgdorferiand human tissue. Ann Neurol. 1989;26:732–737. - PubMed
-
- Asbrink E, Hovmark A. Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis) Ann N Y Acad Sci. 1988;539:4–15. - PubMed
-
- Burgdorfer W, Lane R S, Barbour A G, Gresbrink R A, Anderson J R. The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi. Am J Trop Med Hyg. 1985;34:925–930. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
